# a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects

> **NCT07166796** · PHASE1 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 64 (actual)

## Conditions studied

- Health Subjects

## Interventions

- **DRUG:** singe dose 15mg
- **DRUG:** single dose 30mg
- **DRUG:** single dose 60mg
- **DRUG:** single dose 120mg
- **DRUG:** multi dose 30mg
- **DRUG:** multi dose 60mg

## Key facts

- **NCT ID:** NCT07166796
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-01
- **Primary completion:** 2007-01-31
- **Final completion:** 2007-01-31
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07166796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07166796, "a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07166796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*